PHARMACOKINETICS OF TOTAL AND FREE VALPROIC ACID DURING MONOTHERAPY IN INFANTS

被引:13
|
作者
HERNGREN, L [1 ]
LUNDBERG, B [1 ]
NERGARDH, A [1 ]
机构
[1] KAROLINSKA HOSP,DEPT PAEDIAT,S-10401 STOCKHOLM 60,SWEDEN
关键词
VALPROIC ACID; INFANTS; PROTEIN BINDING; PHARMACOKINETICS;
D O I
10.1007/BF00315328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pharmacokinetics of free and total valproic acid (VPA) in plasma and whole blood after oral administration during steady state was investigated in seven infants (mean age 10.7 months) receiving monotherapy. The VPA concentrations in whole blood closely followed those in plasma but at a reduced level. A positive correlation was found between dose and mean plasma concentration (r = 0.71). Mean terminal half-lives were similar in plasma and whole blood (12.5 and 15.5 h, respectively), but were considerably longer than for free VPA (6.4 and 6.5 h, respectively; P < 0.01). There was a significant decrease in half-lives with increasing age (P < 0.05). Plasma and whole blood clearance for total VPA was higher than reported in older infants and adults (17.8 and 28.9 ml/kg per hour) and was considerably higher for free VPA (127.6 and 188.8 ml/kg per hour, respectively). The increase in clearance compared with that in older subjects is well in concordance with a lower protein binding of VPA (mean 85.3%). Of special importance is that the percentage of unbound VPA increased with increasing concentrations of total VPA. The fraction of unbound VPA in plasma increased even more in subjects with low albumin concentrations (P < 0.01).
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [21] EFFECTS OF EXERCISE ON VALPROIC ACID PHARMACOKINETICS
    MARSH, TD
    GARNETT, WR
    POYNOR, WJ
    PELLOCK, JM
    CLINICAL PHARMACY, 1983, 2 (01): : 62 - 64
  • [22] Stability of free and total valproic acid in specimens assayed by FPIA.
    Yoshimura, HH
    Kincaid, HL
    Alexander, HJ
    King, RB
    CLINICAL CHEMISTRY, 2002, 48 (06) : A58 - A58
  • [23] DISPOSITION AND PHARMACOKINETICS OF VALPROIC ACID IN RATS
    OGISO, T
    ITO, Y
    IWAKI, M
    YAMAHATA, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (07) : 2950 - 2956
  • [24] Valproic acid pathway: pharmacokinetics and pharmacodynamics
    Ghodke-Puranik, Yogita
    Thorn, Caroline F.
    Lamba, Jatinder K.
    Leeder, J. Steven
    Song, Wen
    Birnbaum, Angela K.
    Altman, Russ B.
    Klein, Teri E.
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (04): : 236 - 241
  • [25] CLINICAL PHARMACOKINETICS OF VALPROIC ACID - 1988
    ZACCARA, G
    MESSORI, A
    MORONI, F
    CLINICAL PHARMACOKINETICS, 1988, 15 (06) : 367 - 389
  • [26] ASSESSMENT OF TOTAL AND FREE VALPROIC ACID LEVELS IN SERUM AND PLASMA IN CHILDREN
    GARNETT, WR
    MARCH, CL
    TARASIDIS, C
    PELLOCK, JM
    ANNALS OF NEUROLOGY, 1983, 14 (03) : 369 - 369
  • [27] Population pharmacokinetics of total valproic acid (VPA) concentrations in elderly nursing home residents
    Birnbaum, AK
    Ahn, J
    Brundage, RC
    Conway, JM
    Hardie, NA
    Bowers, SE
    Leppik, IE
    EPILEPSIA, 2004, 45 : 118 - 119
  • [28] RELATIONSHIP BETWEEN SERUM CONCENTRATION AND DOSE OF VALPROIC ACID DURING MONOTHERAPY IN ADULT OUTPATIENTS
    TISDALE, JE
    TSUYUKI, RT
    OLES, KS
    PENRY, JK
    THERAPEUTIC DRUG MONITORING, 1992, 14 (05) : 416 - 423
  • [29] Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
    Lee, Soo-Yun
    Huh, Wooseong
    Jung, Jin Ah
    Yoo, Hye Min
    Ko, Jae-Wook
    Kim, Jung-Ryul
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 4559 - 4563
  • [30] Serum free carnitine levels during valproic acid therapy
    Sarenur Tütüncüoglu
    Husan Tekgül
    Ertürk Levent
    Afig Hüseyinov
    The Indian Journal of Pediatrics, 1997, 64 (4) : 567 - 571